References

1. Migraitan SmPC https://www.medicines.org.uk/emc/product/3463

2. Society’s headache, The socioeconomic impact of migraine. The work foundation April 2018

3. Migraitan® Patient Information Leaflet

4. https://www.nhs.uk/conditions/migraine/on 21/03/2018

5. Headache classification committee of the International Headache society (IHS), The international classification of headache disorders 3rdedition (beta version) 2013, Cephalalgia 33 (9) 629-808

6. Weatherall M. The diagnosis and treatment of chronic migraine, Ther Adv Chronic Dis 2015. Vol 6 (3) 115-123

7. Headache and migraine biology and management

8. WHO, 2010. Global Burden of Disease Survey. Available at: http://www.who.int/topics/global_burden_of_disease/en.

9. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003 Sep; 23(7):519-27

10. British Association for the Study of Headache, 2007. Available at: http://www.migraineclinic.org.uk/wp-content/uploads/2009/08/Bash-Guidelines.pdf

11. Mayo clinic Migraine https://www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201 21/03/2018

12. Migraine headache in adults, BMJ Best Practice last updated Feb 2018 http://bestpractice.bmj.com/topics/en-gb/10/pdf/10.pdf